David L. Katz, MD, MPH, FACPM, FACP, FACLM, is the Founding Director (1998) of Yale University’s Yale-Griffin Prevention Research Center, and current President of the American College of Lifestyle Medicine. He has published roughly 200 scientific articles and textbook chapters, and 15 books to date, including multiple editions of leading textbooks in both preventive medicine, and nutrition. He has made important contributions in the areas of lifestyle interventions for health promotion; nutrient profiling; behavior modification; holistic care; and evidence-based medicine. David earned his BA degree from Dartmouth College (1984); his MD from the Albert Einstein College of Medicine (1988); and his MPH from the Yale University School of Public Health (1993). He completed sequential residency training in Internal Medicine, and Preventive Medicine/Public Health. He is a two-time diplomate of the American Board of Internal Medicine, and a board-certified specialist in Preventive Medicine/Public Health. He has received two Honorary Doctorates.
Our collective, pandemic focus continues to vacillate with the news of the day, but if it has settled anywhere, it has settled of late on the toll of so-called “long COVID,” now known medically as PASC: Post Acute Sequelae of SARS-CoV-2.
On March 8, David Leonhardt wrote in the New York Times about the “mystery” of low COVID mortality in many low-income, resource-constrained countries in Africa and Asia.
The major medical news of this past week, certainly grim and described in many outlets as “staggering,” was the reported decline in average U.S. life expectancy since the onset of the COVID19 pandemic.